Diagnosis of endocrine disease: biochemical diagnosis of phaeochromocytoma and paraganglioma
A Van Berkel, JWM Lenders… - European journal of …, 2014 - academic.oup.com
Adrenal phaechromocytomas and extra-adrenal sympathetic paragangliomas (PPGLs) are
rare neuroendocrine tumours, characterised by production of the catecholamines …
rare neuroendocrine tumours, characterised by production of the catecholamines …
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
JWM Lenders, QY Duh, G Eisenhofer… - The Journal of …, 2014 - academic.oup.com
Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
WT Zandee, K Kamp, RC van Adrichem… - Endocrine-Related …, 2017 - erc.bioscientifica.com
The treatment of hormone hypersecretory syndromes caused by neuroendocrine tumors
(NETs) can be a major challenge. NETs originating from the small intestine often secrete …
(NETs) can be a major challenge. NETs originating from the small intestine often secrete …
Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options
A Vicha, Z Musil, K Pacak - Current Opinion in Endocrinology …, 2013 - journals.lww.com
PHEOs/PGLs are the most inherited tumors among (neuro) endocrine tumors. Future
approaches in genetics, including whole-genome sequencing, will allow the discovery of …
approaches in genetics, including whole-genome sequencing, will allow the discovery of …
Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines
L Cerquetti, B Bucci, R Marchese… - Endocrine-related …, 2008 - erc.bioscientifica.com
Neuroendocrine (carcinoid) tumors (NETs) are endocrine neoplasms occurring most
frequently in gastrointestinal and bronchopulmonary (BP) systems. The majority of patients …
frequently in gastrointestinal and bronchopulmonary (BP) systems. The majority of patients …
Genetics and imaging of pheochromocytomas and paragangliomas: current update
Abstract Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare, heterogeneous
neuroendocrine neoplasms of the autonomous nervous system of chromaffin cell origin that …
neuroendocrine neoplasms of the autonomous nervous system of chromaffin cell origin that …
[HTML][HTML] Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma
TE Osinga, TP Links, RPF Dullaart, K Pacak… - The FASEB …, 2017 - ncbi.nlm.nih.gov
Dopamine is a catecholamine that acts both as a neurotransmitter and as a hormone,
exerting its functions via dopamine (DA) receptors that are present in a broad variety of …
exerting its functions via dopamine (DA) receptors that are present in a broad variety of …
[HTML][HTML] Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
A Vicha, D Taieb, K Pacak - Endocrine-related cancer, 2014 - ncbi.nlm.nih.gov
Warburg's metabolic hypothesis is based on the assumption that a cancer cell's respiration
must be under attack, leading to its damage, in order to obtain increased glycolysis …
must be under attack, leading to its damage, in order to obtain increased glycolysis …
[HTML][HTML] Development of pheochromocytoma in ceramide synthase 2 null mice
WJ Park, O Brenner, A Kogot-Levin… - Endocrine-related …, 2015 - ncbi.nlm.nih.gov
Pheochromocytoma (PCC) and paraganglioma are rare neuroendocrine tumors of the
adrenal medulla and sympathetic and parasympathetic paraganglia, for which mutations in …
adrenal medulla and sympathetic and parasympathetic paraganglia, for which mutations in …
Hereditary pheochromocytoma
P Santos, T Pimenta… - International journal of …, 2014 - journals.sagepub.com
Introduction. Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare
neuroendocrine tumors with an estimated occurrence of 2 to 5 patients per million per year …
neuroendocrine tumors with an estimated occurrence of 2 to 5 patients per million per year …